Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TEAD4 | Q15561 | 1/20 | 0.42 |
| ▸ | HTR2A | P28223 | 2/20 | 0.42 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | AR | P10275 | 1/20 | 0.40 |
| ▸ | MMP13 | P45452 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | KIF11 | P52732 | 2/20 | 0.36 |
| ▸ | NPC1 | O15118 | 2/20 | 0.35 |
| ▸ | RAB9A | P51151 | 2/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | MLYCD | O95822 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16301267 | 0.89 | TSHR (0.42) | HTR2ASLC6A4KCNH2MAPTALDH1A1 | |
| SCHEMBL10085717 | 0.89 | TSHR (0.42) | HTR2ASLC6A4KCNH2MAPTALDH1A1 | |
| SCHEMBL8917191 | 0.82 | ALDH1A1 (0.52) | TEAD4MAPTALDH1A1POLBTDP1 | |
| SCHEMBL14214414 | 0.81 | KIF11 (0.43) | ALDH1A1POLBMEN1KMT2AKIF11 | |
| SCHEMBL18826483 | 0.79 | CA12 (0.44) | KCNH2MAPTALDH1A1TDP1MEN1 | |
| SCHEMBL325272 | 0.79 | TEAD4 (0.47) | TEAD4HTR2ASLC6A4KCNH2MAPT | |
| SCHEMBL15932974 | 0.79 | KMT2A (0.36) | ALDH1A1POLBMEN1KMT2AKIF11 | |
| SCHEMBL9741002 | 0.77 | TEAD4 (0.48) | TEAD4HTR2ASLC6A4KCNH2MAPT | |
| SCHEMBL275843 | 0.77 | TEAD4 (0.48) | TEAD4HTR2ASLC6A4KCNH2MAPT | |
| SCHEMBL457746 | 0.77 | HTR2A (0.53) | TEAD4HTR2ASLC6A4KCNH2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9663617-B2 | Fluorine-containing modified bismaleimide resin | NAN YA PLASTICS CORPORATION (TW) | 2017-05-30 | — | — | US | disclosed |
| US-20160168330-A1 | FLUORINE-CONTAINING MODIFIED BISMALEIMIDE RESIN | NAN YA PLASTICS CORPORATION (TW) | 2016-06-16 | — | — | US | disclosed |
| US-20160111754-A1 | ELECTROLYTE ADDITIVE, ELECTROLYTE AND LITHIUM ION BATTERY USING THE SAME | TSINGHUA UNIVERSITY (CN) | 2016-04-21 | — | — | US | disclosed |
| US-20150210923-A1 | LIQUID CRYSTAL DISPLAY DEVICE AND MANUFACTURING METHOD THEREOF | MAGNOLIA PURPLE CORPORATION (JP) | 2015-07-30 | — | — | US | disclosed |
| US-20150094430-A1 | DINITRO COMPOUND, DIAMINE COMPOUND, AND AROMATIC POLYIMIDE | TAIWAN TEXTILE RESEARCH INSTITUTE (TW) | 2015-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150094430-A1 | DINITRO COMPOUND, DIAMINE COMPOUND, AND AROMATIC POLYIMIDE | DDC, DDT, PARN | TEAD4 1716/4885HTR2A 2849/4885SLC6A4 2411/4885 |
| US-20160111754-A1 | ELECTROLYTE ADDITIVE, ELECTROLYTE AND LITHIUM ION BATTERY USING THE SAME | SLC9B2, EPM2A, SCN2B | TEAD4 1953/4885HTR2A 3871/4885SLC6A4 1019/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.